Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EPRX.TO | NGEN.VN | CYBN.NE | ||
| Company | Eupraxia Pharmaceuticals Inc | Nervgen Pharma Corp | Cybin Inc | ||
| Price Information | |||||
| Exchange | TSX | TSX Venture | Cboe CA | ||
| Open | 8.24 | 5.770 | 8.4000 | ||
| High | 8.72 | 5.990 | 8.5500 | ||
| Low | 8.15 | 5.750 | 8.2800 | ||
| Latest | 8.54 | 5.800 | 8.3400 | ||
| Change | +0.48 | +0.030 | +0.0700 | ||
| % Change | +5.96% | +0.52% | +0.85% | ||
| Volume | 122,078 | 70,654 | 19,166 | ||
| 20-Day Average Volume | 86,537 | 162,805 | 28,716 | ||
| Previous Close | 8.06 | 5.770 | 8.2700 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.78 | 4.504 | 8.4230 | ||
| 20-Day Raw Stochastic | 38.53% | 76.65% | 40.25% | ||
| 20-Day Relative Strength | 51.50 | 66.30 | 47.72 | ||
| Weighted Alpha | +88.44 | +79.78 | -42.82 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 64% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 80% Buy | 8% Buy | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.18% since 11/28/25 | -2.52% since 11/28/25 | -4.25% since 11/28/25 | ||
| Low | 8.06 on 12/04/25 | 5.340 on 12/01/25 | 7.7000 on 12/03/25 | ||
| High | 9.00 on 12/01/25 | 6.580 on 12/03/25 | 8.7100 on 12/01/25 | ||
| 1-Month | |||||
| %Chg | +6.88% since 11/05/25 | +75.23% since 11/05/25 | -0.12% since 11/05/25 | ||
| Low | 7.35 on 11/07/25 | 3.200 on 11/06/25 | 7.7000 on 12/03/25 | ||
| High | 9.88 on 11/14/25 | 6.580 on 12/03/25 | 9.2900 on 11/12/25 | ||
| 3-Month | |||||
| %Chg | +15.88% since 09/05/25 | +53.44% since 09/05/25 | -10.32% since 09/05/25 | ||
| Low | 7.15 on 09/16/25 | 3.200 on 11/06/25 | 7.7000 on 12/03/25 | ||
| High | 9.88 on 11/14/25 | 6.580 on 12/03/25 | 11.1100 on 10/28/25 | ||
| 6-Month | |||||
| %Chg | +55.56% since 06/05/25 | +90.16% since 06/05/25 | -31.07% since 06/05/25 | ||
| Low | 5.20 on 06/16/25 | 2.710 on 08/20/25 | 7.7000 on 12/03/25 | ||
| High | 9.88 on 11/14/25 | 6.580 on 12/03/25 | 12.7100 on 06/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 432,537 | 454,398 | 429,171 | ||
| Shares Outstanding, K | 50,648 | 78,344 | 49,894 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -25,502,536 | -24,005,895 | -79,055,419 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -6,361,367 | -4,156,070 | -33,722,000 | ||
| 60-Month Beta | 1.64 | 1.40 | -0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/04/25 | -0.06 on 11/24/25 | -1.39 on 11/13/25 | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||